Myeloma and Related Diseases Registry (MRDR)

Thanks to MRDR participants and contributing sites who provided data for the latest MRDR publication! - 'Predictors of early mortality in multiple myeloma: Results from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR)'. Access the paper here: https://onlinelibrary.wiley.com/doi/10.1111/bjh.18324

Find out more

This clinical quality registry aims to improve myeloma outcomes by providing an evidence base for the best strategies to diagnose, treat and support people with myeloma and related diseases.

What is the registry?

Learn about how the registry works and the data we collect.
Benefits

Participation in the registry provides advantages for sites and patients.
About our projects

Find out about MRDR projects and how registry data is being used.
5432

Patients accrued

3605

Patients with multiple myeloma

56

Number of approved sites

579

Biobank participants

Latest news

MRDR paper on early mortality in multiple myeloma accepted for publication
15 Jul 2022

Paper on on early mortality in multiple myeloma accepted for publication!

Read more
Rare Disease Day, Monday 28 Feb!
24 Feb 2022

Thanks to those who contribute to improving care, and providing support for people living with myeloma & related diseases!

Read more
MRFF grant for MY-PROMPT-2 trial!
11 Jan 2022

MY-PROMPT-2 project funded!

Read more
5000 patients registered!!
15 Dec 2021

The MRDR reached 5000 registered participants!

Read more

Participating organisations